Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Recent News

10.18 2018
Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference
09.25 2018
Translate Bio to Participate in the Leerink Partners Roundtable Series: Rare Disease & Oncology
08.30 2018
Translate Bio to Participate in Citi’s 13th Annual Biotech Conference
08.09 2018
Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements

View All

@TranslateBio